SCHEMBL23313207

SCHEMBL23313207

COC[C@H]1O[C@@H](n2cc(Cl)c3c(N)ncnc32)[C@@H](F)[C@@H]1O

nearest known ligand 0.66

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 15/20 0.66
▸ METTL3 Q86U44 14/20 0.66
▸ ADK P55263 3/20 0.64
▸ ATG7 O95352 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28713523 0.87 METTL3 (0.60) PRMT5METTL3ADK
SCHEMBL29365731 0.87 METTL3 (0.60) PRMT5METTL3ADK
SCHEMBL29772278 0.80 PRMT5 (1.00) PRMT5METTL3
SCHEMBL23273846 0.80 PRMT5 (1.00) PRMT5METTL3
SCHEMBL381959 0.80 NT5E (0.69) —
SCHEMBL21999782 0.80 NT5E (0.69) —
SCHEMBL23313159 0.79 PRMT5 (1.00) PRMT5METTL3
SCHEMBL16242266 0.78 ADK (0.55) PRMT5METTL3ADK
SCHEMBL8523600 0.78 ADK (1.00) ADK
SCHEMBL8975530 0.78 ADK (0.78) PRMT5METTL3ADK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021079196-A9 METTL3 MODULATORS ACCENT THERAPEUTICS, INC (US) 2022-07-14 — — WO disclosed
WO-2021079196-A2 METTL3 MODULATORS ACCENT THERAPEUTICS, INC (US) 2021-04-29 — — WO disclosed
Send feedback